Guangzhou Kingmed Diagnostics Group Co., Ltd. (603882.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

27.1x

EV/EBITDA

38.1x

Market Cap

CNY 13.77B

MomentumView details →

1D Return

−5.17%

YTD Return

−5.85%

RSI (14)

41.8

ValuationView details →

P/E (Fwd)

27.1x

EV/EBITDA

38.1x

Market Cap

CNY 13.77B

RSI (14)

41.8

MomentumView details →

1D Return

−5.17%

YTD Return

−5.85%

ProfitabilityView details →

Gross Margin

35.15%

Net Margin

−1.74%

EBITDA Margin

4.83%

ROE (TTM)

−1.62%

ROA (TTM)

−1.12%

Asset Turnover

0.63x

GrowthView details →

Revenue YoY

−13.20%

EPS YoY

+73.93%

FCF YoY

+19.03%

Revenue CAGR 3Y

−26.96%

EPS CAGR 3Y

+54.88%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.33

EPS Surprise

1.52%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.26

Avg Surprise (4Q)

1.52%

Rev Surprise

−11.61%

Capital & dividendView details →

Debt/Equity

0.11x

Current Ratio

3.13x

Quick Ratio

3.04x

Div Yield

3.30%

Div Rate

CNY 0.88

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

5.91B

Net Income (TTM)

−102.67M

Op. CF (TTM)

1.19B

Next earningsOct 23, 2026 →

Latest newsMore news →

KingMed Diagnostics established a new wholly-owned subsidiary, Guangzhou Jinkun Medical Laboratory Co., Ltd., with registered capital of 10 million yuan, to engage in medical services and related businesses.3d ago

KingMed Diagnostics announced its 2026 first-half results: net profit attributable to shareholders was 190 million yuan, turning from a loss in the same period last year.12d ago

Similar companies

Charles River Laboratories International, Inc.CRL Revvity, Inc.RVTY ICON Public Limited CompanyICLR Medpace Holdings, Inc.MEDP Joinn Laboratories(China)Co.,Ltd.06127.HK 安图生物603658.SH Find similar companies →

Latest newsMore news →

KingMed Diagnostics established a new wholly-owned subsidiary, Guangzhou Jinkun Medical Laboratory Co., Ltd., with registered capital of 10 million yuan, to engage in medical services and related businesses.3d ago KingMed Diagnostics announced its 2026 first-half results: net profit attributable to shareholders was 190 million yuan, turning from a loss in the same period last year.12d ago